Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma
Oncotarget (2016) - Comments
pubmed: 27769056  doi: 10.18632/oncotarget.12728  issn: 1949-2553 

Judith Hagenbuchner, Martina Rupp, Christina Salvador, Bernhard Meister, Ursula Kiechl-Kohlendorfer, Thomas Müller, Kathrin Geiger, Consolato Sergi, Petra Obexer, Michael J. Ausserlechner